Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial - 15/01/13
On behalf of the ADVANCE Collaborative group
pages | 4 |
Iconographies | 0 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Objective |
Examine the association of oral disease with future dementia/cognitive decline in a cohort of people with type 2 diabetes.
Methods |
A total of 11,140 men and women aged 55–88 years at study induction with type 2 diabetes participated in a baseline medical examination when they reported the number of natural teeth and days of bleeding gums. Dementia and cognitive decline were ascertained periodically during a 5-year follow-up.
Results |
Relative to the group with the greatest number of teeth (more than or equal to 22), having no teeth was associated with the highest risk of both dementia (hazard ratio; 95% confidence interval: 1.48; 1.24, 1.78) and cognitive decline (1.39; 1.21, 1.59). Number of days of bleeding gums was unrelated to these outcomes.
Conclusions |
Tooth loss was associated with an increased risk of both dementia and cognitive decline.
Le texte complet de cet article est disponible en PDF.Keywords : Cognitive decline, Cohort study, Dementia, Oral disease
Plan
Vol 28 - N° 1
P. 49-52 - janvier 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?